您的当前位置:首页 > 行业数据 > 图表44校正安慰剂影响后载脂蛋白B变化情况
图片属性
图片格式:PNG 图片大小:193KB 图片尺寸:1198*849
同报告图片
 / 4
图表44校正安慰剂影响后载脂蛋白B变化情况_第1页
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
图表44校正安慰剂影响后载脂蛋白B变化情况_第2页
图表44校正安慰剂影响后载脂蛋白B变化情况_第3页
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
图表44校正安慰剂影响后载脂蛋白B变化情况_第4页
图表44校正安慰剂影响后载脂蛋白B变化情况_第5页
所属报告: 恒瑞医药(600276)-A股公司深度研究报告系列一:创新与国际化赋能国产创新龙头渐入佳境-250926(41页).pdf
打包全文图表

相关数据

客服
商务合作
小程序
服务号
折叠